![Adesh Kaul](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Adesh Kaul
Finansdirektör/CFO på
BASILEA PHARMACEUTICA AG
Förmögenhet: 1 M $ per 2026-07-31
Profil
Currently, Adesh Kaul is Chief Financial Officer at Basilea Pharmaceutica AG since 2019, with employment at the firm starting in 2009.
Formerly, Mr. Kaul was CFO & Head-Corporate Development at Spexis Ltd. from 2015 to 2016.
Also worked as a Research Analyst at NZB Neue Zürcher Bank AG (Investment Management) and NZB Neue Zürcher Bank AG.
Education includes an MBA from the University of St. Gallen and a graduate degree from the University of Basel.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
BASILEA PHARMACEUTICA AG 0,12 % | 2025-12-31 | 16 205 ( 0,12 % ) | 1 M $ | 2026-07-31 |
Aktiva positioner av Adesh Kaul
| Företag | Position | Start |
|---|---|---|
| BASILEA PHARMACEUTICA AG | Finansdirektör/CFO | 2019-04-10 |
Tidigare kända positioner av Adesh Kaul
| Företag | Position | Slut |
|---|---|---|
| SPEXIS AG | Finansdirektör/CFO | 2016-01-01 |
NZB Neue Zürcher Bank AG (Investment Management)
 NZB Neue Zürcher Bank AG (Investment Management) Major BanksFinance NZB-IM is an active manager which follows a top-down approach. Their investment focus is on the Swiss market. The investment managers use both quantitative and qualitative factors to construct value-oriented portfolios for long-term returns. In addition to their in-house team, they utilize external sources such as experts in taxation, legal, estate- and retirement-planning. | Analyst-Equity | - |
NZB Neue Zürcher Bank AG
 NZB Neue Zürcher Bank AG Investment Banks/BrokersFinance Provides securities and brokerage services | Analyst-Equity | - |
Adesh Kauls utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
38
Första gradens relationer
6
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 6 |
|---|---|
NZB Neue Zürcher Bank AG (Investment Management)
NZB Neue Zürcher Bank AG (Investment Management) Major BanksFinance NZB-IM is an active manager which follows a top-down approach. Their investment focus is on the Swiss market. The investment managers use both quantitative and qualitative factors to construct value-oriented portfolios for long-term returns. In addition to their in-house team, they utilize external sources such as experts in taxation, legal, estate- and retirement-planning. | Finance |
Basilea Pharmaceutica AG
 Basilea Pharmaceutica AG Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
University of St. Gallen
 University of St. Gallen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Basel
 University of Basel Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Spexis Ltd.
 Spexis Ltd. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that focuses on the discovery and development of macrocycle drugs addressing unmet medical needs | Health Technology |
NZB Neue Zürcher Bank AG
NZB Neue Zürcher Bank AG Investment Banks/BrokersFinance Provides securities and brokerage services | Finance |
